CoQ10 is the most-recommended fertility supplement after a prenatal vitamin. Your RE mentioned it. Rebecca Fett's It Starts With the Egg built an entire chapter around it. Every fertility forum has threads debating brands and dosages.
But what did the research actually find? Not \"CoQ10 helps egg quality\" — that's the headline. What were the specific results? How many women were studied? What doses? How long? And how confident should you be that those results apply to you?
Here's every major study, stripped of jargon, with the numbers that matter.
Why CoQ10 Matters for Eggs: The 30-Second Science
Every egg in your ovary is a single cell that must perform the most energy-intensive task in human biology: dividing its chromosomes perfectly from 46 to 23, then sustaining rapid cell division after fertilization. The energy for this process comes from mitochondria, and CoQ10 is the molecule that shuttles electrons through the mitochondrial energy chain.
After about age 30, CoQ10 levels in ovarian tissue begin declining. By 40, they've dropped significantly. Less CoQ10 means less efficient mitochondria, which means less energy for chromosome division, which means higher rates of aneuploidy (chromosomally abnormal eggs). This is the primary mechanism behind age-related egg quality decline.
Supplementing CoQ10 aims to partially restore that mitochondrial energy. Not reverse aging — but give your eggs the fuel they need to do their job.
The Key Studies
Study 1: Xu et al. (2018) — The Landmark IVF Trial
Design: Women aged 35–43 undergoing IVF were randomized to receive 600 mg/day of CoQ10 or placebo for 2 months before their IVF cycle.
Limitation: Study was adequately powered for oocyte/embryo outcomes but underpowered for pregnancy rates. Larger confirmatory trial needed.
Study 2: Ben-Meir et al. (2015) — The Mouse Model That Started Everything
Design: Aged mice (reproductive equivalent of a 38–40-year-old human) were given CoQ10 supplementation. Researchers then examined oocyte quality, mitochondrial function, and pregnancy outcomes.
Limitation: This is a mouse study. Mice aren't humans. But it established the biological mechanism that human trials then tested, and it's the reason REs started recommending CoQ10 at scale.
Study 3: Giannubilo et al. (2018) — CoQ10 Levels in Follicular Fluid
Design: Measured CoQ10 concentration in follicular fluid (the liquid surrounding eggs) during IVF egg retrievals, then correlated levels with embryo quality.
Limitation: Observational — can't prove supplementation causes the increase. But it confirms that CoQ10 does reach the ovarian follicle and that more is correlated with better.
Study 4: Florou et al. (2020) — Meta-Analysis
Design: Pooled data from all available randomized controlled trials on CoQ10 and IVF outcomes.
Limitation: Heterogeneity in dosing, duration, and CoQ10 form across studies. Total sample size still modest. Authors concluded \"promising but definitive trial needed.\"
Ubiquinol vs. Ubiquinone: Does the Form Actually Matter?
This is the most-asked question in every fertility forum, and the answer is more nuanced than supplement companies want you to believe.
Ubiquinone is the oxidized form of CoQ10. It's what most studies used. It's cheaper. Your body converts it to ubiquinol (the active form) before using it.
Ubiquinol is the reduced (active) form. It skips the conversion step. After about age 30, the conversion from ubiquinone to ubiquinol becomes less efficient, which is the argument for taking the active form directly.
| Factor | Ubiquinone | Ubiquinol |
|---|---|---|
| Study evidence | Most clinical trials used this form | Fewer dedicated trials; extrapolated from bioavailability data |
| Absorption | Lower bioavailability | 2–8x higher bioavailability depending on formulation |
| Best for | Under 30 or budget-conscious | Over 30, DOR, or IVF patients wanting maximum absorption |
| Cost | $25–30/month at 600mg | $35–80/month at 400–600mg |
| RE preference | Some accept either | Most REs specify ubiquinol for patients over 30 |
If you're under 30 and budget matters, ubiquinone at 600 mg/day is fine — that's what most studies used. If you're over 30, doing IVF, or have DOR, ubiquinol at 400–600 mg/day gives you the best chance of achieving therapeutic levels in your follicular fluid. The absorption advantage of ubiquinol means you can take a lower dose and still get equal or better tissue levels.
The 90-Day Protocol: What REs Actually Prescribe
Your CoQ10 Timeline
Most REs recommend stopping CoQ10 at a positive pregnancy test. There isn't enough safety data on high-dose CoQ10 (400–600 mg) during pregnancy to recommend continuing it. Low doses (under 200 mg) are likely safe but unnecessary — your prenatal vitamin covers antioxidant needs during pregnancy.
What CoQ10 Can and Can't Do
What CoQ10 can do: Support mitochondrial energy production in developing eggs. Improve the cellular machinery that enables proper chromosome division. Potentially increase the proportion of euploid (chromosomally normal) eggs in a cohort. The effect is most meaningful in women over 35 where mitochondrial decline is the primary driver of egg quality issues.
What CoQ10 cannot do: Reverse menopause. Create new eggs (you were born with all of them). Fix structural issues (blocked tubes, severe endometriosis). Replace IVF when IVF is indicated. Overcome severe diminished ovarian reserve on its own. It's an optimizer, not a miracle worker — and the most important thing you can optimize is getting appropriate medical care when you need it.
Choosing a CoQ10 Product
| Product | Form | Dose | Cost/Month at 600mg | Notes |
|---|---|---|---|---|
| Theralogix NeoQ10 | Ubiquinone w/ VESIsorb | 100mg/cap | ~$150 | 6x absorption, NSF certified. May need only 200mg. |
| Jarrow QH-absorb | Ubiquinol | 200mg/cap | ~$75 | Enhanced absorption. Most popular RE recommendation. |
| Doctor's Best | Ubiquinone + BioPerine | 200mg/cap | ~$45 | Good budget option. Piperine enhances absorption. |
| NOW Ubiquinol | Ubiquinol | 200mg/cap | ~$65 | Solid mid-range. Well-reviewed. |
Our CoQ10 Picks
Based on the forms, doses, and absorption profiles backed by research.